The QualityStocks Daily Newsletter for Wednesday December 23rd, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters




MicroCapVoice (CGEN)


GreenBackers (PSDV)

The QualityStocks Newsletter would like to wish everyone a Safe and Happy Holiday. We will return on Monday December 28th.

The QualityStocks Daily

La Jolla Pharmaceutical Company (LJPC)

Stock Fortune Teller, OTC Picks, Penny Sleuth, HotOTC.com, Cool Penny Stocks, StockEgg.com, Stockpalooza, Penny Invest, and Microcap Voice reported this month on La Jolla Pharmaceutical Company (LJPC), Greenbackers, The Sandman did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Founded in 1989, La Jolla Pharmaceutical Company is dedicated to improving and preserving human life by developing innovative pharmaceutical products. The Company's historical focus was on the development and testing of Riquent® (abetimus sodium), as a treatment for patients with lupus. Lupus is an antibody-mediated disease caused by abnormal B cell production of antibodies that attack healthy tissues.  The Company has also developed small molecules to treat various other autoimmune and inflammatory conditions. La Jolla Pharmaceutical Company trades on NASDAQ and they have their corporate headquarters in San Diego, California.

In February 2009, La Jolla announced that an independent monitoring board for the Riquent® Phase 3 study had completed their review of the first interim efficacy analysis. This board determined that continuing the study was futile. La Jolla subsequently took steps to significantly reduce their operating costs. The Company ceased all Riquent development, manufacturing, and regulatory activities. They proceeded with steps to wind down their operations before entering into a merger agreement with Adamis Pharmaceuticals Corporation.

Yesterday, La Jolla Pharmaceutical Company announced that they have filed their Registration Statement on Form S-4 with the Securities and Exchange Commission. This is in connection with their proposed merger with Adamis Pharmaceuticals Corporation. They entered into the definitive merger agreement on December 4, 2009. Adamis stockholders holding approximately 35 percent of the outstanding common stock of Adamis have agreed to vote in favor of the merger. The expectation is that the merger will close by the end of the first quarter of 2010. If the merger occurs, La Jolla's name will change to Adamis Pharmaceuticals Corporation.

Upon closing, the combined company will focus on the development and commercialization of therapeutic products. These products are for a variety of viral diseases, including hepatitis and influenza. Adamis recently launched a pre-filled Epinephrine syringe. They are looking to generate near-term revenue to support development efforts for product candidates representing larger market opportunities.

La Jolla Pharmaceutical Company (LJPC) closed Wednesday's trading session at $0.1585 down 6.76 percent. Volume was 2,610,053.

Nordic American Tanker Shipping Ltd. (NAT)

Today we are highlighting Nordic American Tanker Shipping Ltd. (NAT), here at the QualityStocks Daily Newsletter.

Nordic American Tanker Shipping Ltd. is an international tanker company. Trading on the New York Stock Exchange (NYSE), the Company owns and operates crude oil tankers. They operate their vessels in the spot market, on time charters or on bareboat charters. Founded in 1995, Nordic American Tanker Shipping Ltd. has their corporate headquarters in Hamilton, Bermuda.

On November 17, 2009, the Company took delivery of the Suezmax vessel that the Company agreed to acquire in early October 2009. The double hull Suezmax vessel goes by the name Nordic Mistral. Including the Nordic Mistral and the acquisition announced November 9, the fleet of the Company consists of 18 Suezmax vessels of which two are newbuildings with delivery expected in May 2010 and August 2010, respectively. The Nordic Mistral will undergo employment in the spot market.

Also in November, Nordic American Tanker Shipping Ltd. announced a dividend for the 49th consecutive quarter. The Company reported that the third quarter was down with a corresponding low dividend of $0.10 per share because of a low freight market. They stated that there are signs of a positive development in the world economy and that the freight market for the fourth quarter has started on a positive note compared with the third quarter.

In the third quarter of 2009, total off-hire (out of service) for the Company's fleet was approximately 40 days of which planned off-hire was approximately 15 days. There are no scheduled dry-dockings for any of the Company's vessels until 2010 when one vessel is scheduled for dry-docking.

Nordic American Tanker Shipping Ltd. grew from 3 to 18 Suezmax crude oil tankers in less than five years. Examples of ship names for the Company are MT Nordic Hunter, MT Nordic Discovery, MT Nordic Apollo, MT Nordic Freedom, and MT Nordic Cosmos, among others.

The Company's vessels are environmentally friendly ships with double-hull. The vessels incorporate additional steel in areas subject to high stress. They also have higher coating specifications to minimize corrosion, and high specification equipment and machinery to reduce maintenance and help protect the environment.

Nordic American Tanker Shipping Ltd. (NAT) closed today at $30.68 up 0.66 percent. Volume was 253,863.

Novavax, Inc. (NVAX)

Greenbackers reported this month on Novavax, Inc. (NVAX), Momentum Traders, Contrarian Press, Penny Invest, StockEgg.com, SmallCapInvestor.com, The Dean, OTC Picks, SmallCap Voice, Wall Street News Alert, The Street, Standout Stocks, Wall Street Grand, and Today's Financial News did earlier, and we are highlighting the Company, here at the QualityStocks Daily Newsletter.    

Trading on the NASDAQ Global Market, Novavax, Inc. is a clinical-stage biotechnology company. They are creating novel vaccines to address a broad range of infectious diseases worldwide, including H1N1, using advanced proprietary virus-like-particle (VLP) technology. The Company produces potent VLP-based, recombinant vaccines utilizing new and efficient manufacturing approaches. Novavax, Inc. has their corporate headquarters in Rockville, Maryland.

Novavax's commitment is to using their VLP technology to create country-specific vaccine solutions. They have formed a joint venture with Cadila Pharmaceuticals, named CPL Biologicals. This joint venture is to develop and manufacture vaccines, biological therapeutics, and diagnostics in India.

Novavax's team has created vaccines designed to protect against various circulating strains of pandemic influenza as well as seasonal flu, Respiratory Syncytial Virus (RSV) and Varicella Zoster Virus (VZV). They have validated their approach in animals and are now in clinical testing with their pandemic and seasonal influenza vaccine. The Company plans to apply their particle-based vaccine approach to other viral diseases beyond influenza.

Using their proprietary virus-like particle (VLP) technology, Novavax scientists build a structure similar to a virus except for the genetic material required for viral replication. They do this without the use of an adjuvant. Upon injection into the body, VLPs attach to cells and trigger an immune response sufficient to protect a person, if they have exposure to the virus.

On December 2, 2009, Novavax, Inc. reported favorable initial results from the first stage of a two-stage pivotal Phase II study evaluating the safety and immunogenicity of their 2009 H1N1 virus-like particle (VLP) pandemic influenza vaccine. Novavax is conducting this study in collaboration with Avimex Laboratories of Mexico. This is to support registration of the vaccine in Mexico and potentially other countries.

The Independent Data and Safety Monitoring Board (DSMB) finds that a single dose of 15 mcg or 45 mcg of H1N1 VLP is well tolerated and produces a robust immune response. Early data show Novavax's VLP vaccine met the seroconversion and seroprotection criteria recommended by the U.S. and European regulatory authorities. In addition, the DSMB recommends 15 mcg single dose vaccine regimen for Stage B (3,000 subjects) of the pivotal study. Enrollment for Stage B has begun.

Novavax, Inc. (NVAX) closed Wednesday's trading session at $2.82 down 2.08 percent. Volume was 1,426,936.

Electronic Game Card Inc. (EGMI)

This month, Greenbackers and SmallCap Voice reported on Electronic Game Card Inc. (EGMI), Penny Performers, Standout Stocks, Penny Invest, Stock Egg did earlier, and we highlight the Company, here at the QualityStocks Daily Newsletter.

Electronic Game Card Inc., through their subsidiaries, engages in the development, marketing, sale, and distribution of recreational electronic software. These are for the gaming, lottery, and sales promotion markets worldwide. Founded in 1981, Electronic Game Card has offices in New York City, and in London, England. They trade on the OTC Bulletin Board.

The Company also develops, produces, and markets innovative games to the toys and games, and sports memorabilia markets around the world. They market their products under the name EGC Electronic GameCard™. This is a credit card-sized pocket game that includes a random number generator. This Electronic GameCard™ comes equipped with a microchip and liquid crystal display screen that shows numbers or icons. It combines the patent-pending proprietary technology of interactive capability with "instant win" properties. It is also programmable to suit different gaming and promotion applications.

Electronic Game Card Inc. develops sales and marketing relationships with agents and distributors worldwide.  They have agents and distributors in North America, United Kingdom, Ireland, Mexico, Italy, South Korea, Sweden, Norway, Denmark, Finland, South Africa, Australia, New Zealand, and Japan.

The Company has a five-year license agreement containing established yearly minimum royalty payments with Arizona based Sovereign Game Cards, LLC. Signed in 2008, this agreement is for distribution of the EGC Electronic GameCard™ into Native American Indian-owned casinos within the United States and Canada. Under the terms of the 5-year exclusive agreement, Sovereign will produce, market, sell, and distribute EGC Electronic GameCard™ units to Native American Indian-owned casinos and Native American Indian charity and beneficial lotteries. EGC will earn royalty fees ranging from 10 percent to 15 percent of the gross selling price of the EGC Electronic GameCard™.

Electronic Game Card, Inc. announced in October that they signed a definitive agreement to partner with China LotSynergy Holdings Ltd. to enter the Chinese lottery market. The two companies are conducting trials in China to ensure optimum offering for the market. China LotSynergy is an established leader in lottery technology in the Chinese Lottery market.

On December 4, 2009, Electronic Game Card, Inc. reported that they signed a worldwide licensing agreement with Bally Technologies, Inc. The licensing agreement provides Electronic Game Card with an immediate increase to their library of games with well-known product from Bally IP brands. Bally Technologies, Inc. is a leading designer, manufacturer, operator, and distributor of advanced gaming devices, systems, and technology solutions.

Electronic Game Card Inc. (EGMI) closed Wednesday's trading session at $1.25 up 7.76 percent. Volume was 565,246.

ChinaTel Group Inc. (CHTL)

Today StockEgg.com and Penny Invest reported on ChinaTel Group Inc. (CHTL), OTC Picks, OTC Stock Review, HotOTC.com, Cool Penny Stocks, Stock Rich did earlier this month, Greenbackers, Stock Stars, All Penny Stocks, Bull Market Newsletter, Standout Stocks, did previously, and we highlight the Company, here at the QualityStocks Daily Newsletter.

ChinaTel Group Inc., through their controlled subsidiaries, provides telecommunications infrastructure engineering and construction services globally. Headquartered in Irvine, California, the countries they serve include the United States, China, Argentina, Peru, and Chile. The Company's subsidiaries have entered into agreements to build and deploy a 3.5GHz wireless broadband system in various cities across China. The Company trades on NASDAQ's OTCBB.

ChinaTel Group Inc.'s goal is to acquire and operate WiMAX networks in key markets throughout the world. They are working to be a leader of Internet technologies. Taking advantage of the WiMAX technology wave, they believe they will have the capabilities of becoming a catalyst of change for the new generation of Internet applications and users. Their corporate strategy is to build leading-edge IP-leveraged solutions advanced by their worldwide infrastructure and leadership in emerging markets.

ChinaTel provides fixed line telephone, conventional long distance, high-speed wireless broadband, and telecommunications infrastructure engineering and construction services. ChinaTel is presently building, deploying, and operating wireless broadband telecommunications networks in Asia and South America.  These include a 3.5GHz wireless broadband telecommunications network in numerous cities across the People's Republic of China. This is with and for CECT-Chinacomm Communications Co., Ltd, a China company that holds a license to build the high-speed wireless broadband system. ChinaTel's projects also include a 2.5GHz, wireless broadband telecommunications network in cities across Peru with and for Perusat, S.A.

ChinaTel Group Inc. now offers a wide range of services and solutions in the areas of system planning, construction, network operations support, tower management and RF Engineering. They also offer Build- to-Suit and Purchase/Leaseback programs. ChinaTel will support all major technology platforms, including fixed, wireless, optical, data, analog, digital, wireless Internet, and broadband wireless technologies.

Last month, ChinaTel Group, Inc. announced that CECT-Chinacomm Communications Co. Ltd. (Chinacomm), a company owned 49 percent by ChinaTel, will provide a wireless telecommunications broadband network for the Beijing Transport Ministry. This network is for 'live' broadcast of information, schedules, advertising and news on the transportation's fleet, as well as security monitoring for those using public transportation in China.

Subsequent to the above announcement, ChinaTel further announced in November that their planned infrastructure growth in the People's Republic of China (PRC) has increased significantly. The PRC's Public Security Ministry has chosen CECT - Chinacomm Communications Co., Ltd. (Chinacomm) to provide national security surveillance services using the state of the art wireless broadband network ChinaTel is currently deploying for Chinacomm. ChinaTel, indirectly through their contractual relationships with Chinacomm, has the right to deploy and operate a wireless broadband telecommunications network in 29 PRC cities (Chinacomm Network).

Today, ChinaTel Group Inc. (CHTL) closed at $1.41 up 29.36 percent. Volume was 2,649,194.

TomoTherapy Incorporated (TOMO)

Today we choose to highlight TomoTherapy Incorporated (TOMO), here at the QualityStocks Daily Newsletter.

TomoTherapy Incorporated develops, markets, and sells advanced radiation therapy solutions for treating a wide variety of cancers. Trading on the NASDAQ, the Company's ring gantry-based TomoTherapy® platform combines integrated CT imaging with conformal radiation therapy to deliver sophisticated radiation treatments with speed and precision while reducing radiation exposure to surrounding healthy tissue. TomoTherapy Incorporated has their headquarters in Madison, Wisconsin.

TomoTherapy Incorporated has their TomoTherapy® Hi·Art® treatment system. Through integrating CT imaging and helical intensity-modulated radiation therapy, the Company's approach improves the effectiveness and efficiency of radiation treatment for the full range of cancer tumors. They now have more than 200 Hi·Art installations in more than 16 countries around the world.

The Company owns multiple issued U.S. patents. They also have a number of patent applications pending, both in the U.S. and worldwide. They also hold an exclusive license on more than 100 issued patents and pending applications globally.

TomoTherapy's suite of solutions include their aforementioned flagship Hi·Art ® treatment system. Its use has delivered more than three million CT-guided, helical intensity-modulated radiation therapy (IMRT) treatment fractions. The Company has their TomoHD ™ treatment system, designed to enable cancer centers to treat a broader patient population with a single device. In addition, they have their TomoMobile ™ relocatable radiation therapy solution, designed to improve access and availability of state-of-the-art cancer care.

On December 8, 2009, TomoTherapy Incorporated announced that they expanded their Institute of Learning curriculum to include a course for radiation oncologists. The design of the course, being offered in partnership with Monmouth Medical Center of Long Branch, N.J., is to introduce physicians to the fundamentals of the TomoTherapy® platform and its use in a clinical setting.

Physicians Mitchell Weiss, M.D., and Sang Sim, M.D., along with physicist Jack Yang, Ph.D., collaboratively teach the radiation oncologist course on TomoTherapy technology.  All of them are members of Monmouth's radiation oncology team. They have been using the TomoTherapy technology since 2008.

TomoTherapy Incorporated (TOMO) closed Wednesday's trading session at $3.98 up 1.79 percent. Volume was 106,799.

Applied NeuroSolutions Inc. (APSN)

Yesterday, PennyOemga.com reported on Applied NeuroSolutions Inc. (APSN), and we highlight the Company today, here at the QualityStocks Daily Newsletter.

Founded in 1991, Applied NeuroSolutions Inc. is a development-stage biopharmaceutical company. Trading on the OTCBB, the Company is focusing on diagnostics and therapeutics for the treatment of Alzheimer's Disease (AD). Applied NeuroSolutions Inc. has a long-term agreement with Albert Einstein College of Medicine (AECOM).  This grants the Company the exclusive licensing rights to commercialize Dr. Peter Davies' neurodegenerative disease related discoveries. The Company is collaborating with Eli Lilly and Company to develop novel therapeutic compounds to treat the progression of AD. Applied NeuroSolutions Inc. has their headquarters in Vernon Hills, Illinois.

The Company's management team and board of directors include experienced scientists from both academic and pharmaceutical settings. They also include senior executives with extensive experience in the development, management, and commercialization of biotech and pharmaceutical products.  Dr. Peter Davies, the Company’s founding scientist, is a world-renowned Alzheimer's disease researcher.

Applied NeuroSolutions Inc.'s long-range goal is to discover and develop novel therapeutics to treat AD.  They are conducting work utilizing an in-vitro screen Dr. Davies developed that could lead to the discovery of a therapeutic to stop the progression of Alzheimer’s disease.  The basis for this screen is the discovery of a common pathway that leads to the development of both the neurofibrillary tangles and amyloid plaques.

Earlier this year, the Company announced that they achieved promising results in their development of a blood-based test related to the diagnosis of patients with Alzheimer's disease. The results of two studies showed the ability of this tau-based test to differentiate between patients with AD and normal controls with sensitivity greater than 80 percent and specificity greater than 70 percent. The studies provided data from blinded serum samples.

Much of Dr. Davies' AD research has been involved within an abnormal form of a protein called tau. This normally serves to stabilize microtubules, the transit system in nerve cells that directs molecules to their destinations.  Excessive phosphorylation of tau prevents it from stabilizing microtubules. Peter Davies, Ph.D., is the Burton P. and Judith Resnick Professor of Alzheimer's Disease Research at Albert Einstein College of Medicine.

On December 8, 2009, Applied NeuroSolutions, Inc. announced that Eli Lilly and Company agreed to a one-year renewal of their drug discovery collaboration. Lilly will pay $250,000 to Applied NeuroSolutions for the one-year collaboration renewal. The original collaboration term was for three years, with two one-year options to extend the collaboration term at Lilly's sole discretion. Lilly exercised the first one-year option.

Yesterday, Applied NeuroSolutions, Inc. announced that they reached agreement with Eli Lilly and Company to increase the scope of their drug discovery collaboration. In addition to the financial terms from the original collaboration agreement with Lilly announced in 2006, Applied NeuroSolutions will receive an up-front cash payment of $750,000 and may receive up to $25.5 million based on achievement of identified milestones. Applied NeuroSolutions would receive royalties for any AD therapies brought to market that result from this addition to the original collaboration agreement.

Applied NeuroSolutions Inc. (APSN) closed at $1.40 up 47.37 percent. Volume was 331,684.

China Biologic Products, Inc. (CBPO)

Stock Stars reported earlier on China Biologic Products, Inc. (CBPO), and we highlight the Company, here at the Quality Stocks Daily Newsletter.

China Biologic Products, Inc. is currently the largest non-state-owned plasma-based biopharmaceutical company in China. The Company conducts their activities through their indirect majority-owned subsidiaries, Shandong Taibang Biological Products Co. Ltd. and Guiyang Dalin Biologic Technologies Co., Ltd., and their equity investment in Xi'an Huitian Blood Products Co., Ltd. They sell their products to hospitals and other healthcare facilities in China. China Biologic Products, Inc. has their corporate headquarters in Tai'an, China. The Company trades on the NASDAQ Global Market.

The Company is a fully integrated biologic products company with plasma collection, production and manufacturing, research and development, and commercial operations. Their plasma-based biopharmaceutical products are used during medical emergencies, and are used for the prevention and treatment of various diseases.

China Biologic Products, Inc. announced in September that on September 11, 2009 the Company entered into a strategic research and development agreement. This is with the Institute of Blood Transfusion (IBT) based in Chengdu, Sichuan Province. The agreement is to strengthen the Company's research and development capabilities and manufacturing processes. IBT is a division of the Chinese Academy of Medical Sciences and Peking Union Medical College (CAMS).

The IBT is a leading research institute in China, specializing in a variety of plasma-based research. China Biologic's collaboration with IBT will include the use of IBT's technology to enhance safe and efficient plasma collection, and increase the range of plasma-derivative products that can be manufactured by the Company. The agreement also entitles China Biologic to utilize IBT's platform technologies.

China Biologic Products, Inc.'s Research and Development team is working to achieve safety of products and maximized yield for each unit volume of plasma. They are focusing on strengthening the breadth and depth of their portfolio of plasma-based biopharmaceutical products, and enhancing the yield per unit volume of plasma through new collection techniques. They are also focusing on improving manufacturing efficiency and safety, promoting product safety through implementation of new technologies, and refining production technology for existing products.

China Biologic Products, Inc. (CBPO) closed Wednesday's session at $11.75 up 3.98 percent. Volume was 67,386.

The QualityStocks Company Corner

eDOORWAYS Corporation (EDWY)

The QualityStocks Daily Newsletter would like to spotlight eDOORWAYS Corporation (EDWY) Today eDoorways Corporation closed trading at $0.0570. Their volume today was 1,441,104 shares.

eDOORWAYS Corp. (EDWY) announced that it has completed the primary series of stress tests on the first beta version of its “SOLVE” doorway. According to the press release, Kimmons and his leadership team were abuzz with excitement last night as they looked forward to this morning’s peer review.

eDOORWAYS Corp. (EDWY) Director of Operations, Lance Kimmons, announced today that the Company has just completed filing all of what appears to be the required documents for OTC/Pinksheets and its website.

eDOORWAYS Corp. (EDWY) is committed to solving lifestyle problems for consumers while driving traffic to suppliers and service providers who offer innovative merchandise and solutions. The company has the potential to completely change the future landscape of business by offering a unique and comprehensive service that saves consumers valuable time and money. By uniting a consumer with the larger global consumer community, retailers, and manufacturers in an effective new way, eDOORWAYS promotes “dynamic” commerce, as opposed to the static model currently in existence.

The Company plans to capitalize on several emerging new trends. These newly created opportunities include: the large success of Web 2.0 Internet community service offerings such as MySpace, the movement towards niche marketing and targeted advertising, the introduction of new technologies that enable instantaneous, online presentation of information, and the rising consumer preference for using the Internet to gain information before making purchasing decisions.

eDOORWAYS plans to introduce local services using a city-by-city strategy that will minimize capital requirements, reduce staffing requirements, and optimize generated revenues. Ten major cities are targeted for launch in the first year. Advertising, PR campaigns and viral word-of-mouth will be used to give a public presentation to experts as well as educate the market.

The key benefits offered to consumers include a higher level of engagement with vendors, trusted information from other consumers, and superior customer service. Revenues will be generated through advertising placement fees, premium services, preferential placement fees, and a percentage of sales transactions. eDOORWAYS' progressive vision and professional management team makes it an attractive investment opportunity. Disclaimer

eDOORWAYS Corporation Blog

eDOORWAYS Corporation News:

eDoorways Completes Requirements to Resolve Caveat Emptor

eDoorways and ISTEC a Step Closer to International Partnership Exposing Company's Doorways to Over 20 Million Online Users Through the Engagement of Professor Ramiro Jordan

eDoorways Provides Greater Detail on "SOLVE" Beta Releases and Functionality

NetSol Technologies, Inc. (NTWK)

The QualityStocks Daily Newsletter would like to spotlight NetSol Technologies, Inc. (NTWK). Today, NetSol Technologies, Inc. closed trading at $1.05, which was up 3.96 percent. Their volume today was 383,454 shares.  

NetSol Technologies, Inc. (NTWK), announced today that they have won a major contract in the area of Information Security with a leading mobile telecommunications company in Pakistan. Along with additional revenues, this contract further strengthens NetSol’s position as a leader in the information security services sector in Pakistan.

NetSol Technologies, Inc. (NTWK), a worldwide provider of global business services and enterprise application solutions, leverages its BestShoring(TM) practices and highly experienced resources to deliver high-quality, cost-effective solutions. Their suite of products and services include credit and finance portfolio management systems, hospital/healthcare information management systems (HIMS), SAP consulting and services, custom development, systems integration, and technical services.

NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by less than 100 companies worldwide. These distinctions are a result of adhering to rigorous quality standards, resulting in the delivery of solutions that are secure, reliable, properly planned, and meticulously executed.

Serving the global financial, healthcare, insurance, energy, and technology markets, NetSol has operations, offices, and joint ventures in Adelaide, Bangkok, Beijing, Lahore, London, Riyadh, San Francisco, and San Pedro Sula. NetSol Technologies' clients include Fortune 500 manufacturers, global automakers, financial institutions, utilities, technology providers, and government agencies.

NetSol Technologies, Inc. (NTWK), is well positioned with its core product offerings as it continues to expand into new international market opportunities. Looking forward, the company is very optimistic of its short-term and long-term outlook as it sees strong growth in Asia Pacific as well as the South East Asian markets, while also envisioning unlimited potential for its niche solutions and services in the Americas. Disclaimer

NetSol Technologies, Inc. Blog

NetSol Technologies, Inc. News:

NetSol Technologies Wins a Major Information Security Contract in the Mobile Telecommunications Sector

NetSol Technologies Issues Financial Guidance for Fiscal Year 2010, Period Ending June 30, 2010

NetSol Technologies to Present at Equities Winter Discovery Day Conference in New York on December 11, 2009

Newport Digital Technologies, Inc. (NPDT)

The QualityStocks Daily Newsletter would like to spotlight Newport Digital Technologies, Inc. (NPDT). Today, Newport Digital Technologies, Inc. closed trading at $0.0260, which was up 4.00 percent. Their volume today was 1,361,666 shares.

Newport Digital Technologies, Inc. (NPDT) offers a rich portfolio of competencies in RFID (Radio-Frequency Identification), WiMAX, eLearning, LED Signage, and Security & Surveillance. Utilizing its technological expertise and creativity, the company enables its customers to take full advantage of the nearly limitless possibilities offered by increasingly sophisticated applications.

Newport is committed to meeting specific customer requirements by delivering complete solutions for a broad spectrum of applications. The company is building a global distribution, licensing, and sales network of industry-leading partners as well as third-party Original Design Manufacturers (ODMs) and component suppliers to ensure its clients world-leading technology with strong local support capabilities.

The company has established a synergistic partnership with Taiwan’s premier technology incubators, the Institute for Information Industry (III) and the Industrial Technology Research Institute (ITRI), under which the company develops and customizes their advanced technologies to meet the needs of businesses across the globe. Having a pool of more than 7,900 engineers and scientists, these R&D powerhouses have developed cutting edge capabilities in fields such as Information Communications Technology (ICT), electronics, and nanotechnology.

Newport’s management team has accumulated a wealth of knowledge and experience within the technology industry as well as the corporate world. Maintaining a strong track record of delivering results to investors and customers, the team retains over two centuries of combined experience. Leveraging each team member’s area of expertise, Newport has established a solid foundation to penetrate emerging technology markets.Disclaimer

Newport Digital Technologies, Inc. Message Board

Newport Digital Technologies, Inc. Blog

Newport Digital Technologies, Inc. News:

Newport Digital Technologies Provides Update on Launch of N37B Rugged Handheld Computing Device; Nears Completion of AT&T Device Certification

SCIA "Saturday Winter Conference" Is a Success

Newport Digital Technologies, Inc. Announces Strategic Change in Senior Management Team as It Prepares for Launch of Its RFID and Wireless Digital Signage Products and Solutions


The QualityStocks Daily Newsletter would like to spotlight VIASPACE (VSPC) Today, VIASPACE closed trading at $0.0205, which was up 1.99 percent. Their volume today was 452,210 shares.

VIASPACE (VSPC) announced that on December 18, 2009, they received an extension until January 15, 2010 for the second closing of their purchase of Inter-Pacific Arts, and on the same day they filed an amended Form S-1 with the Securities and Exchange Commission to list their majority-owned subsidiary, VIASPACE Green Energy Inc. (VGE), as a separately reporting public company.

VIASPACE (VSPC) a clean energy company growing Giant King™ Grass as a low-carbon, renewable energy crop, today provided an update on the status of the initial public offering of their majority owned subsidiary VIASPACE Green Energy.

VIASPACE (VSPC) is a clean energy company focused on providing products and technology that reduce or eliminate dependence on fossil fuels and other high-pollutant energy sources. Through its subsidiaries, the company provides raw material for cellulosic biofuels; develops and markets fuel cartridges, products and technology for methanol fuel cells; markets rechargeable lithium-ion batteries; and develops security-related monitoring and detection technology and systems for military/defense and commercial applications.

Through its renewable energy subsidiary, VIASPACE Green Energy, the company grows a fast-growing non-food grass that can be harvested four times a year. This proprietary grass is used for producing low carbon liquid biofuels such as cellulosic ethanol, methanol and green gasoline for transportation, as well as partially or completely replacing coal to reduce carbon emissions from electric power plants. Cellulosic biofuels made from non-food sources offer environmental and economic advantages over food crops, like corn, and are attracting strong political support around the world.

Through its alternative energy subsidiary, Direct Methanol Fuel Cell Corporation, the company designs and manufactures disposable methanol fuel cartridges that supply power for portable electronics such as notebook computers and mobile phones. Compared to traditional batteries, fuel cells cleanly and efficiently convert methanol into electricity without burning and provide longer operating time and instantaneous recharging. VIASPACE also supplies rechargeable lithium batteries for electronics, power tools, electric bicycles and other electric vehicles.

Through its high-technology subsidiary, Ionfinity, the company collaborates with Caltech and NASA’s Jet Propulsion Laboratory to develop and commercialize new sensor technology that can detect very small amounts of hazardous materials such as explosives, chemical/biological weapons, toxic gases and drugs. Leveraging Ionfinity’s miniaturization technology, new portable monitoring devices and detection systems are being developed for homeland security, defense, biomedical, industrial process control, agricultural and environmental safety applications. Disclaimer



First Giant King Grass Harvest

VIASPACE Expands Giant King(TM) Grass Production Capacity

VIASPACE Files Amended Form S-1

NetSol Technologies, Inc. (NTWK) Up Over 30% Since Being Featured by QualityStocks

Wednesday of last week, QualityStocks initiated coverage of NetSol Technologies, Inc. (NTWK). Since then the stock has risen from $0.80 to a high of $1.08 for gains of 35%! Volume has also increased substantially from a daily average of 105,657 to as high as 673,500 traded shares in a single day.

NetSol Technologies, Inc. leverages its BestShoring(TM) practices and highly experienced resources to deliver high-quality, cost-effective solutions. Their suite of products and services include credit and finance portfolio management systems, hospital/healthcare information management systems (HIMS), SAP consulting and services, custom development, systems integration, and technical services.

NetSol’s commitment to quality is demonstrated by its achievement of the ISO 9001, ISO 27001, and SEI (Software Engineering Institute) CMMI (Capability Maturity Model) Maturity Level 5 assessments, a distinction shared by less than 100 companies worldwide. These distinctions are a result of adhering to rigorous quality standards, resulting in the delivery of solutions that are secure, reliable, properly planned, and meticulously executed.

Analysts are very supportive of the company with an average price target of $2.25. NetSol Technologies recently issued improved financial guidance expectations for its full year fiscal 2010 period ending June 30, 2010. Revenues are anticipated to be between $33.0 million and $35.0 million, representing growth of between 25% and 32%. The company also projects a return to GAAP net income versus a GAAP net loss of $0.30 per diluted share for fiscal year 2009.

NetSol’s years of capital investment in its offerings has the company extremely well positioned as demand amongst fortune 500 clients surges worldwide. Looking forward, the company is very optimistic of its short-term and long-term outlook as it sees strong growth in Asia Pacific as well as the South East Asian markets, while also envisioning unlimited potential for its niche solutions and services in the Americas.

General Environmental Management, Inc. (GEVI) Moves Forward With Sales and Acquisitions

General Environmental Management Inc. recently completed the acquisition of Santa Clara Waste Water (SCWW), a profitable full-service environmental services company focusing on waste water treatment. SCWW has been doing business for over 50 years, and has treated more than 2 billion gallons of waste water. It’s listed as one of the top 100 privately owned non-hazardous waste water utilities in the country.

The acquisition was financed through the issuance of six promissory notes, totaling $9,003,000, along with warrants for the principals of SCWW to purchase 425,000 shares of GEM common stock. The interest rate for the notes is 6½% per annum. Two of the notes, totaling $3,778,000, are convertible into a total of 15% of GEM’s common stock on a fully diluted basis.

The acquisition is seen as one of several major actions taken by General Environmental Management (GEM) to improve the company’s balance sheet and focus on new and more profitable markets, including the sale of GEM Mobile Treatment Services and the execution of an agreement to sell the field services business unit.

GEM CEO, Tim Koziol, commented earlier on the moves, “Taken together, these strategic moves have created a foundation for GEM to take advantage of opportunities that we believe will lead to profitability and positive cash flow in the coming year. Our shareholders should look at the current quarterly report as a reflection of a work in progress. Our intention is to continue to focus on higher margin business opportunities in the water treatment and waste-to-energy markets in order to maximize shareholder value of our company’s stock. We are very pleased with the progress and advancements the company has made the past few months, especially when considering the difficult economic environment.”

Koziol added, “Concluding the sale of our field services business will result in a dramatic improvement of our balance sheet, and will result in a lean business that will put profitability and cash generation as the top priorities. We firmly believe our hard work will pay off once we’ve fully transitioned to the faster-growing water treatment and waste-to-energy markets. After the foundation is laid, we will focus our efforts on building a regional and then national presence.”

eDoorways Corp. (EDWY) Announces Successful Completion of Stress Tests on “SOLVE” Beta v1.0

eDoorways Corporation announced that it has completed the primary series of stress tests on the first beta version of its “SOLVE” doorway. Only the user acceptance test remains to declare the platform “road ready,” According to the press release, Kimmons and his leadership team were abuzz with excitement last night as they looked forward to this morning’s peer review.

Gary Kimmons, Chairman & CEO of eDoorways Corporation, stated, “We have put the platform through many rigorous paces, and it has performed up to the expectations we’ve envisioned for our first version of the ‘SOLVE’ beta. For the past two years we have been talking, planning and working toward this moment, and today, with such a long road behind us, I have a feeling of great accomplishment.”

The first version of “SOLVE” will offer premium connectivity between businesses and consumers. Consumers will be able to ask questions and initiate searches. Incorporating the use of PowerKeys, Businesses or Solution Providers with the most relevance will be returned in the top spots of the search list. During this first phase, solution providers will need to be online to get a good search ranking.

“As previously mentioned, we intend to deploy several releases of the ‘SOLVE’ beta,” stated Kimmons. “What we’re doing is no different than what any technology company, such as Google — who happened to have been in beta for nearly four years, does behind the scenes in order to work out the kinks of their service offering; continuously develop and deploy multiple versions of the product until its right.”

Kimmons added, “The only difference with us is, in our attempt to achieve a respectable and responsible level of transparency, while delivering a functioning viable product to the market place this holiday season of 2009, we’re offering the public a look at our beta roll out schedule for ‘SOLVE.’ In our opinion, doing this will assist both shareholders and users to better understand exactly how the platform works today, and what developments to expect over the next year.”

The company has at least 4 additional versions of the beta slated for release during 2010 after the 2009 holiday release of v1.0, beginning with v2.0 (ETA – Late February 2010). The primary release of “SOLVE” will be in the form of Beta v3.0 (ETA – 4th Quarter of 2010). Beta v3.0 is expected to be the first true representation of eDoorways operating as one of the earliest Web 3.0 service offerings within an open source environment.

Kimmons concluded, “The platform for the most part is ready to hit the Internet, and starting with Austin, Texas, we’re going to begin the roll-out shortly providing all goes well today. So all I can say is hold on to your hats because this is going to be one exciting ride!”

Those close to company are also very excited about the holiday release of “SOLVE” Beta v1.0 as it is the year’s most notable milestone for eDoorways.

Magnum D’Or Resources, Inc. (MDOR) Acquires Additional Tire Disposal Client in Colorado

Magnum D’Or Resources, Inc. announced a new off-the-road (OTR) tire collection and disposal client today. Located in Northern California, MDOR’s new client is the largest new and refurbished tire dealer in the entire region. Having already received over 70k pounds (35 tons) of OTR tires, and with a potential to exceed 50 tons per month in the future, MDOR is well positioned to exploit its innovative reprocessing technologies.

Magnum, through its partner SRI, controls a host of proprietary green technologies for rubber reprocessing, making MDOR poised to explode globally as one of the only major contenders in this emerging sector. Things are really coming together for MDOR as this new client announcement follows directly on the heels of additional new clients recently acquired at their Hudson facility, including Weld County, Colorado.

COO of Magnum USA Bryan Brammer spoke of his pleasure regarding the new client, saying “OTR tires represent a very unique product due to the quality and quantity of rubber used in manufacturing”.

Brammer went on to point out how exciting it was to find new clients like this, and how amazingly fast the business was growing, reinforcing MDOR’s commitment to a very “green” environmental philosophy.

Brammer pointed out that MDOR is currently negotiating with several more potential clients, including cities, counties and entities outside the continental United States, and expressed his delight at being part of MDOR’s success story in creating “a cleaner and greener Colorado while also increasing revenue streams”.

Magnum has several major facilities, including a 98k sq. ft. Quebec location which specializes in rubber crumb, buffing and nuggets for a variety of applications. The company currently holds in excess of $130M in open contracts and has a wholly owned engineering subsidiary developing turnkey solutions for the burgeoning environmental recycling industry.


Sponsors of the Day


The QualityStocks Public Company Sponsor News



About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-374-1336